Trichomegaly associated with panitumumab: Case report
PDF

Case report

Trichomegaly associated with panitumumab: Case report

Acta Haematol Oncol Turc 2018;51(1):91-93 DOI: 10.5505/aot.2018.83097
, , , , ,
PDF
Permissions

Abstract

Epidermal growth factor receptor (EGFR) inhibitors are widely used in the treatment of malignant epithelial tumors. Trichomegaly is a rare side effect while skin toxicity is the most common side effect of using these agents. In here, a 48-year-old female with trichomegaly using panitumumab due to metastatic colon carcinoma was presented in the literature.

Keywords: panitumumab, trichomegaly, colorectal carcinoma